Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lesaka Technologies (LSAK) Shares Outstanding (2021 - 2025)

Lesaka Technologies (LSAK) has disclosed Shares Outstanding for 17 consecutive years, with $81.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding rose 1.7% year-over-year to $81.5 million, compared with a TTM value of $81.5 million through Dec 2025, up 1.7%, and an annual FY2025 reading of $81.2 million, up 26.41% over the prior year.
  • Shares Outstanding was $81.5 million for Q4 2025 at Lesaka Technologies, roughly flat from $81.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $89.8 million in Q2 2024 and bottomed at -$24.9 million in Q3 2022.
  • Average Shares Outstanding over 5 years is $61.8 million, with a median of $64.4 million recorded in 2023.
  • The sharpest move saw Shares Outstanding crashed 130.44% in 2022, then surged 355.3% in 2023.
  • Year by year, Shares Outstanding stood at $57.9 million in 2021, then grew by 10.07% to $63.8 million in 2022, then grew by 1.09% to $64.4 million in 2023, then grew by 24.39% to $80.2 million in 2024, then increased by 1.7% to $81.5 million in 2025.
  • Business Quant data shows Shares Outstanding for LSAK at $81.5 million in Q4 2025, $81.5 million in Q3 2025, and $81.2 million in Q2 2025.